Synthesis of ApoSense compound [18F]2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid ([18F]NST732) by nucleophilic ring opening of an aziridine precursor.

Nuclear Medicine and Biology
Falguni BasuliGary L Griffiths

Abstract

The small molecule 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid (NST732) is a member of the ApoSense family of compounds, capable of selective targeting, binding and accumulation within cells undergoing apoptotic cell death. It has application in molecular imaging and blood clotting particularly for monitoring antiapoptotic drug treatments. We are investigating a fluorine-18-radiolabeled analog of this compound for positron emission tomography studies. We prepared the tosylate precursor methyl 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(tosyloxymethyl)butanoate (4) to synthesize fluorine-18-labeled NST732. Fluorination reaction of the tosylate precursor in 1:1 acetonitrile:dimethylsulfoxide with tetrabutyl ammonium fluoride proceeds through an aziridine intermediate (4A) to afford two regioisomers: 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-fluorobutanoate (5) and methyl 2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoate (6). Acid hydrolysis of the fluoromethylbutanoate (6) isomer produced NST732. As the fluorination reaction of the tosylate precursor proceeds through an aziridine intermediate (4A) and the fluorination conceivably could be done directly on the az...Continue Reading

References

Jan 1, 1984·International Journal of Nuclear Medicine and Biology·M DiksicW Feindel
Nov 1, 1995·The Journal of Experimental Medicine·B VerhovenP Williamson
Nov 1, 1996·International Journal of Radiation Biology·M M WeilK A Mason
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·F G BlankenbergH W Strauss
Dec 10, 2003·The Lancet Oncology·Wei Hu, John J Kavanagh
Mar 24, 2005·Infection and Immunity·Susan L Fink, Brad T Cookson
May 10, 2005·Nuclear Medicine and Biology·Heather G KeenJamal Zweit
May 12, 2005·European Journal of Radiology·Juhana M Hakumäki, Timo Liimatainen
Dec 1, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Maya DamianovichAnat Shirvan
Dec 13, 2005·Nuclear Medicine Communications·Hiroshige WatanabeHitoshi Shibuya
Jan 24, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J-F CailhierM-J Hébert
Mar 16, 2006·Journal of the American Chemical Society·Kwangmeyung KimIck Chan Kwon
Oct 20, 2006·Apoptosis : an International Journal on Programmed Cell Death·Revital AloyaIlan Ziv
Mar 3, 2007·Brain Research·Ayelet ReshefIlan Ziv
Mar 17, 2007·Chemistry : a European Journal·Carlos AydilloAlberto Avenoza
May 31, 2007·Technology in Cancer Research & Treatment·Avi CohenAnat Shirvan
Oct 9, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J L Fernández-Luna
Nov 13, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Frank J P HoebersMarcel Verheij
Mar 28, 2008·Journal of Cellular and Molecular Medicine·Narendra ThapaIn-San Kim
Jul 1, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Francis G Blankenberg
Aug 16, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ayelet ReshefIlan Ziv
Sep 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jonathan F Tait
Nov 11, 2008·Current Pharmaceutical Design·Francis G Blankenberg
Jan 28, 2009·Apoptosis : an International Journal on Programmed Cell Death·Hagit GrimbergIlan Ziv
Feb 19, 2009·Cell Research·Avi CohenIlan Ziv
Aug 22, 2009·Cancer Biotherapy & Radiopharmaceuticals·Christel VangestelMarc Peeters
Apr 21, 2010·Bioconjugate Chemistry·Israt S AlamKevin M Brindle
May 21, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ayelet ReshefIlan Ziv
Sep 2, 2010·Revista española de cardiología·Carmen CristóbalJuan C Martínez
Oct 13, 2010·Bioconjugate Chemistry·In-Cheol SunKwangmeyung Kim
Oct 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gang Niu, Xiaoyuan Chen
Oct 22, 2010·Journal of Neural Transmission·X ZhangCheng Wang

❮ Previous
Next ❯

Citations

Mar 13, 2018·Medicinal Research Reviews·Anna A RybczynskaAren van Waarde
Apr 11, 2015·ChemistryOpen·Christina Schjoeth-EskesenNic Gillings

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.